Abstract
Docetaxel (taxotere) had successfully prolonged the survival time in a 59-year-old woman with breast cancer having distan metastases to the liver, lung, lymphnodes and bone. Adverse side effects included febrile neutropenia and reactive pleural effusion. The former was avoided by giving fractionated doses, but the later limitted the sequential administration. Despite, a partial response was gained for both the liver and lung metastases, the patient died of brain metastasis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
